22 February 2018 (Thursday) - Oncologist Newsletter

The Oncologist Newsletter arrived in my in-box today

Access the Most-Read Research from The Oncologist In a constantly changing field, hematology and oncology professionals must stay at the cutting edge of new diagnostic and therapeutic advances for the benefit of their patients. To that end, The Oncologist is committed to helping clinicians improve outcomes for their patients, and we are pleased to provide you with complimentary access to our most-read content. Register and Read The Oncologist Receive New Content Alerts Most-Read Articles in Hematology Oncology FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy Vishal Bhatnagar, Nicole J. Gormley, Lola Luo, Yuan Li Shen, Rajeshwari Sridhara, Sriram Subramaniam, Guoxiang Shen, Lian Ma, Stacy Shord, Kirsten B. Goldberg, Ann T. Farrell, Amy E. McKee, Richard Pazdur Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri, Monali Desai, Jalaja Potluri, Nicole Lamanna, Constantine Tam Best Practices in Chronic Myeloid Leukemia Monitoring and Management Simona Soverini, Caterina De Benedittis, Manuela Mancini, Giovanni Martinelli Most-Read Articles in Medical Oncology Transitions in Prognostic Awareness Among Terminally Ill Cancer Patients in Their Last 6 Months of Life Examined by Multi‐State Markov Modeling Chen Hsiu Chen, Fur‐Hsing Wen, Ming‐Mo Hou, Chia‐Hsun Hsieh, Wen‐Chi Chou, Jen‐Shi Chen, Wen‐Cheng Chang, Siew Tzuh Tang Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations Laura M. Spring, Mark L. Zangardi, Beverly Moy, Aditya Bardia Preventing and Managing Toxicities of High-Dose Methotrexate Scott C. Howard, John McCormick, Ching-Hon Pui, Randall K. Buddington, R. Donald Harvey